TY - JOUR
T1 - Prevalence and correlates of oral human papillomavirus infection among healthy males and females in Lima, Peru
AU - Rosen, Brian J.
AU - Walter, Leora
AU - Gilman, Robert H.
AU - Cabrerra, Lilia
AU - Gravitt, Patti E.
AU - Marks, Morgan A.
N1 - Funding Information:
Institutional Review Board of PRISMA; Ethics review board of the Institution of National Health of Peru (ethics committee approval number CE1006.009/036-2013-CI-INS).
PY - 2016/3
Y1 - 2016/3
N2 - Purpose The incidence of human papillomavirus (HPV) associated head and neck cancers (HNCs) have been increasing in Peru. However, the burden of oral HPV infection in Peru has not been assessed. The objective of this cross-sectional study was to estimate the prevalence and correlates of oral HPV infection in a populationbased sample from males and females from Lima, Peru. Methods Between January 2010 and June 2011, a population-based sample of 1099 individuals between the ages of 10 and 85 from a low-income neighbourhood in Lima, Peru was identified through random household sampling. Information on demographic, sexual behaviours, reproductive factors and oral hygiene were collected using intervieweradministered questionnaires. Oral rinse specimens were collected from each participant, and these specimens were genotyped using the Roche Linear Array assay. ORs were used to assess differences in the prevalence of any oral HPV and any high-risk oral HPV infection by demographic factors, sexual practices and oral hygiene among individuals 15+ years of age. Results The prevalence of any HPV and any high-risk HPV (HR-HPV) was 6.8% and 2.0%, respectively. The three most common types were HPV 55 (3.4%), HPV 6 (1.5%) and HPV 16 (1.1%). Male sex (aOR, 2.21; 95% CI 1.22 to 4.03) was associated with any HPV infection after adjustment. Conclusions The prevalence of oral HPV in this study was similar to estimates observed in the USA. Higher prevalence of oral infections in males was consistent with a male predominance of HPV-associated HNCs and may signal a sex-specific aetiology in the natural history of infection.
AB - Purpose The incidence of human papillomavirus (HPV) associated head and neck cancers (HNCs) have been increasing in Peru. However, the burden of oral HPV infection in Peru has not been assessed. The objective of this cross-sectional study was to estimate the prevalence and correlates of oral HPV infection in a populationbased sample from males and females from Lima, Peru. Methods Between January 2010 and June 2011, a population-based sample of 1099 individuals between the ages of 10 and 85 from a low-income neighbourhood in Lima, Peru was identified through random household sampling. Information on demographic, sexual behaviours, reproductive factors and oral hygiene were collected using intervieweradministered questionnaires. Oral rinse specimens were collected from each participant, and these specimens were genotyped using the Roche Linear Array assay. ORs were used to assess differences in the prevalence of any oral HPV and any high-risk oral HPV infection by demographic factors, sexual practices and oral hygiene among individuals 15+ years of age. Results The prevalence of any HPV and any high-risk HPV (HR-HPV) was 6.8% and 2.0%, respectively. The three most common types were HPV 55 (3.4%), HPV 6 (1.5%) and HPV 16 (1.1%). Male sex (aOR, 2.21; 95% CI 1.22 to 4.03) was associated with any HPV infection after adjustment. Conclusions The prevalence of oral HPV in this study was similar to estimates observed in the USA. Higher prevalence of oral infections in males was consistent with a male predominance of HPV-associated HNCs and may signal a sex-specific aetiology in the natural history of infection.
UR - http://www.scopus.com/inward/record.url?scp=84958935835&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958935835&partnerID=8YFLogxK
U2 - 10.1136/sextrans-2014-051942
DO - 10.1136/sextrans-2014-051942
M3 - Article
C2 - 26275415
AN - SCOPUS:84958935835
SN - 1368-4973
VL - 92
SP - 149
EP - 154
JO - Sexually transmitted infections
JF - Sexually transmitted infections
IS - 2
ER -